Survival of AIDS patients according to type of AIDS-defining event

International Journal of Epidemiology

Volumn 26, Issue 2, 1997, Pages 400-407

  Mocroft, A J ^a   Lundgren, J D ^b   D'Arminio Monforte, A ^c   Ledergerber, B ^d   Barton, S E ^e   Vella, S ^f   Katlama, C ^g   Gerstoft, J ^h   Pedersen, C ^b   Phillips, A N ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b HVIDOVRE HOSPITAL   (Denmark)

^c UNIVERSITY OF MILAN   (Italy)

^d Schweizerische HIV Kohortenstudie   (Switzerland)

^e St Stephens Clinic   (United Kingdom)

^f ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h Rigshospitalet   (Denmark)

Author keywords

Age; AIDS; CD4 lymphocyte count; Ranking; Survival

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BRAIN LYMPHOMA; EUROPE; FEMALE; HUMAN; KAPOSI SARCOMA; LYMPHOCYTE COUNT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NONBIOLOGICAL MODEL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RISK; SURVIVAL; SURVIVAL TIME; TUBERCULOSIS;

EID: 0030966773     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/26.2.400     Document Type: Article

References (28)

1. Lundgren J D, Pedersen C, Clumeck N et al. Survival differences in European patients with AIDS, 1979-89. Br Med J 1994; 308: 1068-73.
2. Luo K, Law M, Kaldor J M, McDonald A M, Cooper D A. The role of initial AIDS-defining illness in survival following AIDS. AIDS 1995; 9: 57-63.
3. Marasca G, McEvoy M. Length of survival of patients with acquired immune deficiency syndrome in the United Kingdom. Br Med J 1986; 292: 1727-29.
4. Bacchetti P, Osmond D, Chaisson R E et al. Survival patterns of the first 500 patients with AIDS in San Francisco. J Infect Dis 1988; 157: 1044-47.
5. Whyte B, Swanson C E, Cooper D A. Survival of patients with the acquired immunodeficiency syndrome in Australia. Med J Aust 1989; 150: 358-62.
6. Lemp G F, Payne S F, Neal D, Temelso T, Rutherford G W. Survival trends for patients with AIDS. JAMA 1990; 263: 402-06.
7. Friedland G H, Saltzman B, Vileno J, Freeman K, Schrager L K, Klein R S. Survival differences in patients with AIDS. J Acquire Immun Defic Syndr 1991; 4: 144-53.
8. Chang H H, Morse D L, Noonan C et al. Survival and mortality patterns of an acquired immunodeficiency syndrome (AIDS) cohort in New York state. Am J Epidemiol 1993; 138: 341-49.
9. Saah A J, Hoover D R, He Y, Kingsley L A, Phair J P, and the Multicentre AIDS Cohort Study (MACS). Factors influencing survival after AIDS: Report from the Multicentre AIDS Cohort Study (MACS). J Acquir Immun Defic Syndr 1994; 7: 287-95.
10. Fischl M A, Richmann D D, Grieco M H et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: A double blind, placebo controlled trial. N Engl J Med 1987; 317: 185-94.
11. Volderbing P A, Lagakos S W, Koch M A et al. Zidovudine in asymptomatic human immunodeficiency virus infection: A controlled trial in persons with less than 500 CD4-positive cells per cubic millimetre. N Engl J Med 1990; 322: 941-49.
12. Hamilton J D, Hartigan P H, Simberkoff M S et al. A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection: Results of the veterans affairs cooperative study. N Engl J Med 1992; 327: 581-87.
13. Hanson D L, Horsburgh C R, Fann S A, Havlik J A, Thompson S E. Survival prognosis of HIV-infected patients. J Acquir Immun Defic Syndr 1993; 6: 624-29.
14. Mocroft A J, Johnson M A, Sabin C A et al A proposed staging system for clinical AIDS patients. Lancet 1995; 346: 12-17.
15. Neaton J D, Wentworth D H, Rame F. Considerations in choice for a clinical endpoint for AIDS clinical trials. Stat Med 1994; 13: 2107-25.
16. Rabeneck L, Wray N P. Predicting the outcomes of human immunodeficiency virus infection. How well are we doing? Arch Intern Med 1993; 153: 2749-55.
17. Crowe S M, Carlin J B, Stewart K I, Lucas C R, Hoy J F. Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquir Immun Defic Syndr 1991; 4: 770-76.
18. Lifson A R, Darrow W W, Hessol N A et al. Kaposi's sarcoma in a cohort of homosexual and bisexual men: Epidemiology and analysis for cofactors. Am J Epidemiol 1990; 131: 221-31.
19. Levine A M, Sullivan-Halley J, Pike M C et al. Human immunodeficiency virus-related lymphoma: Prognostic factors predictive of survival. Cancer 1991; 68: 2466-72.
20. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987; 36 (Suppl. 1S): 1S-5S.
21. SAS Institute Inc. SAS Users Guide: Statistics, 3rd Edn. Version 6. Cary, NC, 1990.
22. Whitmore-Overton E, Tillet H E, Evans B G, Allardice G M. Improved survival from a diagnosis of AIDS in adult cases in the United Kingdom and bias due to reporting delays. AIDS 1993; 7: 711-18.
23. Jacobson L P, Kirby A, Polk S et al. Change in survival after Acquired Immunodeficiency Syndrome (AIDS): 1984-1991. Am J Epidemiol 1993; 138: 952-64.
24. Osmond D, Charlebois E, Lang W, Shiboski S, Moss A. Changes in AIDS survival times in two San Francisco cohorts of homosexual men, 1983-1993. JAMA 1994; 271: 1083-87.
25. Pedersen C, Barton S E, Chiesi A et al. HIV-related non-Hodgkin's lymphoma among European AIDS patients. Eur J Haematol 1995; 55: 245-50.
26. Hoover D R, Black C, Jacobson L P et al. Epidemiological analysis of Kaposi's sarcoma as an early and later AIDS outcome in homosexual men. Am J Epidemiol 1993; 138: 266-78.
27. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded case definition for AIDS among adolescents and adults. MMWR 1992; 41: (RR-17) 1-17.
28. Caiaffa W T, Vlahov D, Graham N M et al. Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus seropositive injecting drug users. Am J Respir Crit Care Med 1994; 150: 1493-98.